Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Bought by BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 61.0% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 67,891 shares of the medical equipment provider's stock after acquiring an additional 25,714 shares during the period. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp's holdings in Intuitive Surgical were worth $30,201,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Gilbert & Cook Inc. grew its holdings in Intuitive Surgical by 6.5% in the fourth quarter. Gilbert & Cook Inc. now owns 3,437 shares of the medical equipment provider's stock worth $1,160,000 after purchasing an additional 211 shares during the period. TrinityPoint Wealth LLC increased its position in Intuitive Surgical by 21.5% during the 4th quarter. TrinityPoint Wealth LLC now owns 1,081 shares of the medical equipment provider's stock valued at $365,000 after buying an additional 191 shares in the last quarter. Hilltop Holdings Inc. increased its position in Intuitive Surgical by 36.2% during the 4th quarter. Hilltop Holdings Inc. now owns 5,387 shares of the medical equipment provider's stock valued at $1,817,000 after buying an additional 1,432 shares in the last quarter. Artisan Partners Limited Partnership boosted its holdings in Intuitive Surgical by 53.5% in the fourth quarter. Artisan Partners Limited Partnership now owns 63,851 shares of the medical equipment provider's stock worth $21,541,000 after acquiring an additional 22,264 shares in the last quarter. Finally, Mitchell Sinkler & Starr PA grew its stake in shares of Intuitive Surgical by 13.7% in the fourth quarter. Mitchell Sinkler & Starr PA now owns 1,622 shares of the medical equipment provider's stock worth $547,000 after acquiring an additional 195 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of Intuitive Surgical stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. In other news, EVP Robert Desantis sold 1,413 shares of the business's stock in a transaction dated Friday, July 26th. The shares were sold at an average price of $438.60, for a total value of $619,741.80. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,414,931.60. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, SVP Henry L. Charlton sold 40,243 shares of the company's stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares of the company's stock, valued at approximately $1,461,006.84. The disclosure for this sale can be found here. Insiders sold 53,120 shares of company stock worth $25,528,753 over the last 90 days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Trading Down 1.0 %

Intuitive Surgical stock traded down $4.89 during mid-day trading on Tuesday, hitting $484.18. The stock had a trading volume of 716,393 shares, compared to its average volume of 1,497,824. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $496.18. The firm has a market capitalization of $171.74 billion, a P/E ratio of 88.28, a P/E/G ratio of 5.41 and a beta of 1.39. The firm's 50 day moving average is $469.05 and its 200 day moving average is $426.06.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.24. The company had revenue of $2.01 billion for the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The firm's quarterly revenue was up 14.5% on a year-over-year basis. During the same quarter last year, the company earned $1.18 EPS. As a group, equities research analysts forecast that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Morgan Stanley lifted their price target on Intuitive Surgical from $375.00 to $460.00 and gave the stock an "equal weight" rating in a research report on Monday, July 15th. Redburn Atlantic upgraded shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and upped their target price for the stock from $380.00 to $510.00 in a research note on Friday, August 2nd. Citigroup raised their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the company a "buy" rating in a research report on Thursday, August 22nd. JPMorgan Chase & Co. upped their price objective on Intuitive Surgical from $475.00 to $495.00 and gave the company an "overweight" rating in a research report on Friday, July 19th. Finally, BTIG Research lifted their target price on Intuitive Surgical from $469.00 to $494.00 and gave the stock a "buy" rating in a report on Wednesday, August 28th. Six research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average price target of $446.45.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.